Diabetes Clinical Trials

Showing 7161-7180 of 7,874 trials

Glycemic Holter Study (Continuous Glucose Monitoring) -

NCT01193296

The study will assess glycemic variability and optimized glycemic control in T2DM patients treated with a DPP-4 inhibitor as add-on therapy to metformin.

Type 2 Diabetes Mellitus

Novartis36 participantsStarted Jun 2010

Bondy, France • Corbeil, France • Marseille, France +4 more locations

COMPLETEDPhase 2/3

Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients

NCT00562952

Increased levels of NT-proBNP are known to increase the risk of cardiac events in diabetic patients. The other way around, patients with normal values have an excellent prognosis on short-term. We intend in our study to proof the hypothesis, whether it is possible to decrease NT-proBNP levels by intensified cardiac prevention care We aim those patients, who already have elevated levels, although no history of a cardiac disease. This decrease in NT-proBNP should be translated consequently in a decrease in cardiac events

Diabetes MellitusHeart FailureCoronary Artery Disease

Medical University of Vienna300 participantsStarted Nov 2007

Vienna, Austria • Vienna, Austria

COMPLETEDPhase 1

Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

NCT00572650

This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and its metabolites in patients with mild renal impairment compared to their sex, age and weigh based healthy volunteer counterparts.

Type 2 Diabetes Mellitus

Novartis29 participantsStarted Oct 2007

Kiel, Germany

Glycemic Holter Study (Continuous Glucose Monitoring) -

Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients

Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

Related Searches

Automated Diabetes Registry Tools to Enhance Patient Self-Management and Provider Performance Feedback

Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device

IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations

Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease

Pharmaceutical Care of Patients With Impaired Mobility in a Model-region of Decreasing Supply of Medical Services

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Metabolic Effects of a Pre-meal Protein Drink With or Without Added Amino Acids at a Subsequent Composite Meal

Point of Care HbA1c as a Screening Test for Type 2 Diabetes in First Nations

Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor

The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus

Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease

Assessment of the Clinical Efficacy and Acceptability of Think Positive (T+) in Diabetes Management

Effect of Meal Frequency on Insulin Resistance in Subjects With Type 2 Diabetes

Periodontal and Periapical Inflammation and Pregnancy

A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus